US equities |
MU $905.07 ▼-0.99% NVDA $216.95 ▼-1.97% SNDK $1,348.33 ▼-3.92% SPCX $146.70 ▼-3.59% AMD $551.94 ▼-3.31% INTC $93.89 ▼-4.31% AAPL $342.42 ▼-0.16% TSM $418.65 ▼-2.64%
FinancialContent

Latest News about Type 2 Diabetes

Recent news which mentions Type 2 Diabetes

Setback For Novo Nordisk? Denmark Shifts Prescription Guidelines, Favoring Cost-Effective Alternatives For Ozempic
Tickers NEWS NVO
Tags News Benzinga NVO
From Benzinga
Australia's Eucalyptus Adds Ozempic To Weight-Loss Drug Lineup After Initial Resistance
Tags Top Stories Market News Media
From Benzinga
Author Reveals the Ultimate Solution for the Diabetes Epidemic
Tags Research Epidemic United States
From PRLog
Better Therapeutics' Diabetes Digital Therapeutic Shows Better Glycemic Control Vs. Standard Care
Tickers BTTX
Tags Movers Benzinga BTTX
From Benzinga
ICER's Report Suggests Benefits Of Eli Lilly's Tirzepatide Not Better Than Other Diabetes Drugs
Tickers LLY NVO
Tags LLY General Briefs
From Benzinga
Metacrine Posts Data From MET409 Combination Trial In Diabetes, NASH Patients
Tickers LLY MTCR
Tags Phase 2 Trial General LLY
From Benzinga
Inventiva Plans To Start Lanifibranor Combo Study In NASH, Diabetes In 2022
Tickers IVA LLY
Tags News Benzinga Briefs
From Benzinga
Eli Lilly Shares Positive Tirzepatide Data At EASD Annual Meeting
Tickers LLY
Tags Phase 3 Trial Market News Health Care
From Benzinga
Bayer's Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes
Tickers AZN BAYRY BAYZF JNJ
Tags Type 2 Diabetes Market News Biotech
From Benzinga